Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Due to the insidiousness of HCC onset and the lack of specific early-stage markers, the early diagnosis and treatment of HCC are still unsatisfactory, leading to a poor prognosis. Exosomes are a type of extracellular vesicle...

Full description

Bibliographic Details
Main Authors: Yulai Zeng, Shuyu Hu, Yi Luo, Kang He
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/9/2365
_version_ 1827724405849980928
author Yulai Zeng
Shuyu Hu
Yi Luo
Kang He
author_facet Yulai Zeng
Shuyu Hu
Yi Luo
Kang He
author_sort Yulai Zeng
collection DOAJ
description Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Due to the insidiousness of HCC onset and the lack of specific early-stage markers, the early diagnosis and treatment of HCC are still unsatisfactory, leading to a poor prognosis. Exosomes are a type of extracellular vesicle containing various components, which play an essential part in the development, progression, and metastasis of HCC. A large number of studies have demonstrated that exosomes could serve as novel biomarkers for the diagnosis of HCC. These diagnostic components mainly include proteins, microRNAs, long noncoding RNAs, and circular RNAs. The exosome biomarkers showed high sensitivity and high specificity in distinguishing HCC from health controls and other liver diseases, such as chronic HBV and liver cirrhosis. The expression of these biomarkers also exhibits correlations with various clinical factors such as tumor size, TMN stage, overall survival, and recurrence rate. In this review, we summarize the function of exosomes in the development of HCC and highlight their application as HCC biomarkers for diagnosis and prognosis prediction.
first_indexed 2024-03-10T22:15:21Z
format Article
id doaj.art-612e8e275c3e43c3af70f9f133d9a052
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T22:15:21Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-612e8e275c3e43c3af70f9f133d9a0522023-11-19T12:28:47ZengMDPI AGPharmaceutics1999-49232023-09-01159236510.3390/pharmaceutics15092365Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular CarcinomaYulai Zeng0Shuyu Hu1Yi Luo2Kang He3Department of Liver Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Liver Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Liver Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Liver Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai 200127, ChinaHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Due to the insidiousness of HCC onset and the lack of specific early-stage markers, the early diagnosis and treatment of HCC are still unsatisfactory, leading to a poor prognosis. Exosomes are a type of extracellular vesicle containing various components, which play an essential part in the development, progression, and metastasis of HCC. A large number of studies have demonstrated that exosomes could serve as novel biomarkers for the diagnosis of HCC. These diagnostic components mainly include proteins, microRNAs, long noncoding RNAs, and circular RNAs. The exosome biomarkers showed high sensitivity and high specificity in distinguishing HCC from health controls and other liver diseases, such as chronic HBV and liver cirrhosis. The expression of these biomarkers also exhibits correlations with various clinical factors such as tumor size, TMN stage, overall survival, and recurrence rate. In this review, we summarize the function of exosomes in the development of HCC and highlight their application as HCC biomarkers for diagnosis and prognosis prediction.https://www.mdpi.com/1999-4923/15/9/2365exosomehepatocellular carcinomabiomarkermicroRNAlong noncoding RNAcircular RNA
spellingShingle Yulai Zeng
Shuyu Hu
Yi Luo
Kang He
Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
Pharmaceutics
exosome
hepatocellular carcinoma
biomarker
microRNA
long noncoding RNA
circular RNA
title Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
title_full Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
title_fullStr Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
title_full_unstemmed Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
title_short Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
title_sort exosome cargos as biomarkers for diagnosis and prognosis of hepatocellular carcinoma
topic exosome
hepatocellular carcinoma
biomarker
microRNA
long noncoding RNA
circular RNA
url https://www.mdpi.com/1999-4923/15/9/2365
work_keys_str_mv AT yulaizeng exosomecargosasbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma
AT shuyuhu exosomecargosasbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma
AT yiluo exosomecargosasbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma
AT kanghe exosomecargosasbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma